Skip to main content
. 2020 Mar 9;2(3):100096. doi: 10.1016/j.jhepr.2020.100096

Table 1.

A summary of the demographics, treatment and outcome of individual cases presenting with late-onset ALF in WD from the previous literature, NHSBT data and current case.

Age Sex Tx Outcome Cp (g/L) [>0.15] s-Cu (μmol/L) [11-20] ncb-Cu (μmol/L)[<2.4] u-Cu (μmol/day) [>1.6] Reference/Source
64 F No Died 0.18 16.5 7.5 14.1 Amano et al. 201815
58 F No Died 0.12 11.4 5.4 Danks et al. 199016
54 F Yes Survived 0.18 14.0 5.1 35.7 Gow et al. 200012
44 F No Died 0.14 28.0 21.1 Danks et al. 199016
44 F No Died 0.14 27.4 20.5 Gow et al. 200012
44 F Yes Died 0.25 58.3 45.9 139.3 Kerber et al. 200314
42 F Yes Survived Bellary et al. 199313
55 F No (Delisted) NHSBT registry
45 F Yes Survived NHSBT registry
44 M Yes Survived NHSBT registry
43 M Yes Survived NHSBT registry
41 F Yes Died NHSBT registry
41 M Yes Survived NHSBT registry
40 M Yes Survived NHSBT registry
40 M Yes Survived NHSBT registry
62 M Yes Survived 0.13 16.7 10.3 Current case

Abnormal results are highlighted in bold with reference ranges in brackets.

ALF, acute liver failure; Cp, caeruloplasmin; s-Cu, serum copper; ncb-Cu, non-caeruloplasmin-bound copper; NHSBT, NHS blood and transplant; Tx, transplantation; u-Cu, urinary copper output; WD, Wilson's disease.

Denotes biochemical parameters that are calculated from other values.